Inventor · disambiguated record
Kehdih Lai
Also filed as: LAI KEHDIH
5 granted patents·4 pending applications·1 citations·filing 2019–2024
63Inventor score
Top patents by PatentIndex Score
9 records- 0180US11622547B2Genetically modified mouse that expresses human albuminREGENERON PHARMA·Filed 2020·Granted Apr 11, 2023·1 cites·12 claims
- 0274US12317874B2Method of using a genetically modified mouse that expresses human albuminREGENERON PHARMA·Filed 2023·Granted Jun 3, 2025·0 cites·30 claims
- 0371US2025255940A1Compositions and methods for expressing factor ixINTELLIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0466US2024190996A1Factor xi catalytic domain-binding antibodies and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0562US12214023B2Compositions and methods for expressing factor IXINTELLIA THERAPEUTICS INC·Filed 2019·Granted Feb 4, 2025·0 cites·16 claims
- 0659US12304969B2Factor XI A2 domain-binding antibodies and methods of use thereofREGENERON PHARMA·Filed 2022·Granted May 20, 2025·0 cites·20 claims
- 0756US2022354967A1Compositions and methods for transgene expression from an albumin locusINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0856US2020270617A1Compositions and methods for transgene expression from an albumin locusINTELLIA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0940US12068729B2Anti-factor XII/XIIa antibodies and uses thereofREGENERON PHARMA·Filed 2019·Granted Aug 20, 2024·0 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Kehdih Lai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →